semaglutide after stopping In the original clinical trials looking at (the GLP-1 in Novo Nordisk's Ozempic and Wegovy) and tirzepatide (in Eli Lilly's Mounjaro and Zepbound), patients gained back most of the weight How to Prevent Weight Regain

And if your situation is more complex long-term plateau, bloodwork questions, or a full protocol audit we offer a $300 Advanced Troubleshooting Consultation with a complete nutrition and training review plus 7-day follow-up support.

Working closely with healthcare providers ensures that hormonal and metabolic well-being remains supported over the long term, even after discontinuing GLP-1 therapy

Context is everything

2022;39(1):e14676

Both peptides show promise for working, but because they work in different ways, are safer, and need to be sourced in different ways, they can be used in different ways for study and practical purposes in managing obesity and diabetes